B. Arroll, C. Elley, and T. Fishman, Antidepressants versus placebo for 66 depression in primary care, Cochrane Database Syst Rev, issue.3, pp.67-007954, 2009.

R. Araya, The management of depression in primary health care, Current Opinion in Psychiatry, vol.12, issue.1, p.69
DOI : 10.1097/00001504-199901000-00026

T. Suh and J. Gallo, Symptom profiles of depression among general medical ser- 71

M. Zimmerman, I. Chelminski, and M. Posternak, Generalizability of antidepres- 80

M. Zimmerman, J. Mattia, and M. Posternak, Are subjects in pharmacological 84

S. Wisniewski, A. Rush, and A. Nierenberg, Can phase III trial results of 98

F. Naudet, A. Maria, and B. Falissard, Antidepressant Response in Major Depressive Disorder: A Meta-Regression Comparison of Randomized Controlled Trials and Observational Studies, PLoS ONE, vol.300, issue.6, pp.20811-103, 2011.
DOI : 10.1371/journal.pone.0020811.s002

R. Van-der-lem, N. Van-der-wee, and T. Van-veen, Efficacy versus Effectiveness: A Direct Comparison of the Outcome of Treatment for Mild to Moderate Depression in Randomized Controlled Trials and Daily Practice, Psychotherapy and Psychosomatics, vol.81, issue.4, pp.226-260, 2012.
DOI : 10.1159/000330890

M. Koesters, G. Guaiana, and A. Cipriani, Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials, The British Journal of Psychiatry, vol.203, issue.3, pp.179-87, 2013.
DOI : 10.1192/bjp.bp.112.120196

D. Taylor, A. Sparshatt, S. Varma, and O. Olofinjana, Antidepressant efficacy of 112 agomelatine: meta-analysis of published and unpublished studies, BMJ, vol.113, issue.348, pp.1888-114, 2014.

. Solenn, 97 boulevard de Port Royal, p.116